Bank of America’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.07M | Buy |
974,173
+141,582
| +17% | +$1.23M | ﹤0.01% | 3039 |
|
|
2025
Q4 | $6.24M | Buy |
832,591
+13,325
| +2% | +$135K | ﹤0.01% | 3208 |
|
|
2025
Q3 | $7.12M | Sell |
819,266
-77,804
| -9% | -$465K | ﹤0.01% | 3656 |
|
|
2025
Q2 | $3.33M | Buy |
897,070
+198,762
| +28% | +$699K | ﹤0.01% | 4301 |
|
|
2025
Q1 | $2.26M | Buy |
698,308
+313,428
| +81% | +$1.48M | ﹤0.01% | 4581 |
|
|
2024
Q4 | $2.14M | Buy |
384,880
+116,024
| +43% | +$910K | ﹤0.01% | 4382 |
|
|
2024
Q3 | $2.91M | Buy |
268,856
+41,257
| +18% | +$685K | ﹤0.01% | 4236 |
|
|
2024
Q2 | $4.78M | Buy |
227,599
+108,042
| +90% | +$2.71M | ﹤0.01% | 3667 |
|
|
2024
Q1 | $3.81M | Sell |
119,557
-45,799
| -28% | -$1.17M | ﹤0.01% | 3870 |
|
|
2023
Q4 | $3.35M | Buy |
165,356
+27,826
| +20% | +$366K | ﹤0.01% | 3904 |
|
|
2023
Q3 | $1.75M | Buy |
137,530
+35,022
| +34% | +$586K | ﹤0.01% | 4382 |
|
|
2023
Q2 | $1.85M | Sell |
102,508
-90,375
| -47% | -$1.66M | ﹤0.01% | 4293 |
|
|
2023
Q1 | $3.32M | Buy |
192,883
+115,471
| +149% | +$2.25M | ﹤0.01% | 3918 |
|
|
2022
Q4 | $1.72M | Buy |
77,412
+57,509
| +289% | +$888K | ﹤0.01% | 4391 |
|
|
2022
Q3 | $160K | Sell |
19,903
-2,044
| -9% | -$18.5K | ﹤0.01% | 6111 |
|
|
2022
Q2 | $153K | Sell |
21,947
-86,033
| -80% | -$836K | ﹤0.01% | 6264 |
|
|
2022
Q1 | $1.63M | Buy |
107,980
+20,533
| +23% | +$322K | ﹤0.01% | 4790 |
|
|
2021
Q4 | $1.92M | Buy |
87,447
+74,824
| +593% | +$1.83M | ﹤0.01% | 4608 |
|
|
2021
Q3 | $341K | Buy |
12,623
+1,608
| +15% | +$45.9K | ﹤0.01% | 5924 |
|
|
2021
Q2 | $265K | Buy |
11,015
+4,138
| +60% | +$127K | ﹤0.01% | 5884 |
|
|
2021
Q1 | $297K | Buy |
6,877
+6,837
| +17,093% | +$303K | ﹤0.01% | 5751 |
|
|
2020
Q4 | $2K | Buy |
+40
| New | +$1.65K | ﹤0.01% | 6936 |
|
Other funds holding FDMT
RCM
NHAS
BI
VCM
AC
